BSI Proteomics is able to provide high resolution images of the drug binding site of protein kinases, which provides a more accurate model for rational drug design. Dynamic Crystallization™ technologies provide structures of kinases. With the completion of its proprietary Dynamic Crystallization platforms, BSI is targeting soluble and ion channel proteins to provide insights and competitive advantages into understanding drug delivery targets.